Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun Ma

Showing results (381-390 of 562) with videos related to

Pageof 57
Sort By:
Journal of Cellular Physiology|November 9, 2017
Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemiaJing-Dong Zhou, Ting-Juan Zhang, Xi-Xi Li, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|March 15, 2019
Prevalence of and Factors Influencing Anti-Tuberculosis Treatment Non-Adherence Among Patients with Pulmonary Tuberculosis: A Cross-Sectional Study in Anhui Province, Eastern ChinaXue-Hui Fang, Hui-Hui Shen, Wan-Qian Hu, et al.
Biological & Pharmaceutical Bulletin|July 5, 2006
Effects of four Si-Wu-Tang's constituents and their combination on irradiated miceQian-De Liang, Yue Gao, Hong-Ling Tan, et al.
Clinical Epigenetics|April 13, 2018
<i>H19</i> overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemiaTing-Juan Zhang, Jing-Dong Zhou, Wei Zhang, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|August 15, 2015
Serum Pharmacochemistry Analysis Using UPLC-Q-TOF/MS after Oral Administration to Rats of Shenfu DecoctionJia-le He, Jia-Wei Zhao, Zeng-Chun Ma, et al.
Journal of Cellular and Molecular Medicine|December 4, 2019
EZH2 dysregulation: Potential biomarkers predicting prognosis and guiding treatment choice in acute myeloid leukaemiaMing-Qiang Chu, Ting-Juan Zhang, Zi-Jun Xu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 13, 2016
DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemiaJing-Dong Zhou, Ting-Juan Zhang, Yu-Xin Wang, et al.
Journal of Biomolecular Structure & Dynamics|October 19, 2019
Identification of novel inhibitor of protein tyrosine phosphatases delta: structure-based pharmacophore modeling, virtual screening, flexible docking, molecular dynamics simulation, and post-molecular dynamics analysisYang-Chun Ma, Bing Yang, Xin Wang, et al.
Journal of Cancer Research and Clinical Oncology|May 5, 2017
Reduced intensity conditioning of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia in patients older than 50 years of age: a systematic review and meta-analysisZhi-Hui Zhang, Xin-Yue Lian, Dong-Ming Yao, et al.
Oncoimmunology|February 1, 2020
The M2 macrophage marker <i>CD206</i>: a novel prognostic indicator for acute myeloid leukemiaZi-Jun Xu, Yu Gu, Cui-Zhu Wang, et al.
Pageof 57

Showing results (381-390 of 562) with videos related to

Sort By:
Pageof 57
Journal of Cellular Physiology|November 9, 2017
Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemiaJing-Dong Zhou, Ting-Juan Zhang, Xi-Xi Li, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|March 15, 2019
Prevalence of and Factors Influencing Anti-Tuberculosis Treatment Non-Adherence Among Patients with Pulmonary Tuberculosis: A Cross-Sectional Study in Anhui Province, Eastern ChinaXue-Hui Fang, Hui-Hui Shen, Wan-Qian Hu, et al.
Biological & Pharmaceutical Bulletin|July 5, 2006
Effects of four Si-Wu-Tang's constituents and their combination on irradiated miceQian-De Liang, Yue Gao, Hong-Ling Tan, et al.
Clinical Epigenetics|April 13, 2018
<i>H19</i> overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemiaTing-Juan Zhang, Jing-Dong Zhou, Wei Zhang, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|August 15, 2015
Serum Pharmacochemistry Analysis Using UPLC-Q-TOF/MS after Oral Administration to Rats of Shenfu DecoctionJia-le He, Jia-Wei Zhao, Zeng-Chun Ma, et al.
Journal of Cellular and Molecular Medicine|December 4, 2019
EZH2 dysregulation: Potential biomarkers predicting prognosis and guiding treatment choice in acute myeloid leukaemiaMing-Qiang Chu, Ting-Juan Zhang, Zi-Jun Xu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 13, 2016
DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemiaJing-Dong Zhou, Ting-Juan Zhang, Yu-Xin Wang, et al.
Journal of Biomolecular Structure & Dynamics|October 19, 2019
Identification of novel inhibitor of protein tyrosine phosphatases delta: structure-based pharmacophore modeling, virtual screening, flexible docking, molecular dynamics simulation, and post-molecular dynamics analysisYang-Chun Ma, Bing Yang, Xin Wang, et al.
Journal of Cancer Research and Clinical Oncology|May 5, 2017
Reduced intensity conditioning of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia in patients older than 50 years of age: a systematic review and meta-analysisZhi-Hui Zhang, Xin-Yue Lian, Dong-Ming Yao, et al.
Oncoimmunology|February 1, 2020
The M2 macrophage marker <i>CD206</i>: a novel prognostic indicator for acute myeloid leukemiaZi-Jun Xu, Yu Gu, Cui-Zhu Wang, et al.
Pageof 57